Quarterly report [Sections 13 or 15(d)]

Stockholders' Equity (Tables)

v3.26.3
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2026
Stockholders' Equity  
Schedule of Stock-Based Compensation Expense

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended September 30, 

​

​

Nine Months Ended September 30, 

($ in thousands)

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

​

2026

  ​ ​ ​

2025

Fortress:

​

​

​

​

​

​

​

​

​

​

​

​

​

Employee and non-employee awards

​

$

665

​

$

990

​

​

$

2,432

​

$

6,514

Executive awards

​

 

102

​

 

167

​

​

 

369

​

 

527

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Partner Companies:

​

 

​

​

​

​

​

​

​

​

​

​

​

Avenue

​

 

47

​

 

163

​

​

 

169

​

 

523

Checkpoint

​

 

—

​

 

—

​

​

 

—

​

 

14,097

Mustang

​

 

2

​

 

23

​

​

 

45

​

 

106

Journey

​

​

1,333

​

​

1,854

​

​

​

3,759

​

​

4,513

Other

​

 

—

​

 

—

​

​

 

8

​

 

—

Total stock-based compensation expense

​

$

2,149

​

$

3,197

​

​

$

6,782

​

$

26,280

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended September 30, 

​

​

Nine Months Ended September 30, 

($ in thousands)

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

​

2026

  ​ ​ ​

2025

Research and development

​

$

31

​

$

152

​

​

$

89

​

$

6,245

Selling, general and administrative

​

 

2,118

​

 

3,045

​

​

 

6,693

​

 

20,035

Total stock-based compensation expense

​

$

2,149

​

$

3,197

​

​

$

6,782

​

$

26,280

Schedule of Restricted Stock Awards and Restricted Stock Units

​

​

​

​

​

​

​

  ​ ​ ​

​

  ​ ​ ​

Weighted

​

​

​

​

average grant

​

​

Number of shares

​

price

Unvested balance at December 31, 2025

​

3,841,748

​

$

3.62

Restricted stock granted

​

1,087,458

​

​

3.22

Restricted stock vested

​

(65,162)

​

​

17.27

Restricted stock vested - settlement deferred1

​

(236,611)

​

​

22.94

Restricted stock units granted

​

470,000

​

​

3.16

Restricted stock units forfeited

​

(150,000)

​

​

1.72

Restricted stock units vested

​

(399,221)

​

​

16.03

Restricted stock units vested - settlement deferred1

​

(752,874)

​

​

3.28

Unvested balance at September 30, 2026

​

3,795,338

​

$

5.84

​

Note 1:

The Company offers certain executives and employees the opportunity to defer settlement of vested restricted stock and vested restricted stock units as part of our deferred compensation plan.

Schedule of Warrant activities

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Total weighted

​

Weighted average

​

​

​

​

​

​

​

average

​

remaining

​

​

Number of

​

Weighted average

​

 intrinsic

​

contractual life

​

  ​ ​ ​

shares

  ​ ​ ​

exercise price

  ​ ​ ​

value

  ​ ​ ​

(years)

Outstanding as of December 31, 2025

 

13,431,502

​

$

2.21

​

$

—

 

3.55

Exercised

​

(694,296)

​

​

1.74

​

​

—

​

—

Outstanding as of September 30, 2026

 

12,737,206

​

$

2.24

​

$

6,256,169

 

2.80

Exercisable as of September 30, 2026

 

12,737,206

​

$

2.24

​

$

6,256,169

 

2.80